Skip to content
No results
  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • 2025-10-01

Triumph Financial, Inc. (NASDAQ:TFIN) Shifts Listing And Accelerates $18–$20M Annual Cost Reductions

Triumph Financial moves through a structural reset after a planned exchange transfer and a targeted workforce reduction, concentrating near-term emphasis on cost savings and payments-platform execution.

  • 2025-10-01

HealthEquity, Inc. (NASDAQ:HQY) Projects Margin Strength To Support Near-Term Momentum

HealthEquity shows operating profitability gains alongside compressing topline growth, producing a setup where margin strength should underpin near-term price stability. Technical indicators point to low trend strength with mixed momentum signals that favor range-bound action with modest upward bias.
  • 2025-10-01

Thomson Reuters Corporation (NYSE:TRI) Launches $1.0B Buyback To Support Shares

Thomson Reuters shows capital-return action while momentum indicators point to near-term downside pressure. Operational metrics deliver mixed signals for valuation and short-term price direction.
  • 2025-10-01

Vaxcyte, Inc. (NASDAQ:PCVX) Secures U.S. Fill‑Finish Pact, Tightening Commercial Readiness

Momentum in manufacturing partnerships and constructive short-term technicals point toward a near-term positive bias for the stock. Fundamental strength in liquidity contrasts with ongoing operating losses and negative free cash flow.

  • 2025-10-01

DoubleVerify Holdings, Inc. (NYSE:DV) Poised For Rebound Amid Strong Cash Position And Contrasting Technical Signals

Product rollouts and a hefty cash balance support a constructive near-term view, while technicals present contrasting momentum cues that could dictate short-term price direction.

  • 2025-10-01

Cogent Communications Holdings, Inc (NASDAQ:CCOI) Boosts Capital Returns While Operational Strains Persist

Cogent projects continued cash returns even as operational margins and leverage weigh on valuation. The near-term technical picture shows mixed momentum that could produce short-lived mean reversion against persistent fundamental pressure.
  • 2025-10-01

Eagle Bancorp, Inc. (NASDAQ:EGBN) Poised For Near-Term Downside As Technicals Turn Bearish

Weak second-quarter profitability combined with a WMDST over-valued assessment places immediate downside pressure on the shares. Technical momentum and model-based measures favor a higher probability of price contraction over the coming weeks.
  • 2025-10-01

SPS Commerce, Inc. (NASDAQ:SPSC) Shows Weak Momentum Ahead Of Near-Term Consolidation

SPS Commerce registers technical weakness and valuation pressure heading into the next six weeks, with fundamentals showing modest growth but stretched multiples. Recent corporate events create informational catalysts while price action favors range-bound behavior with limited upside.
  • 2025-10-01

Vital Energy, Inc. (NYSE:VTLE) Agrees To Crescent Takeover, Immediate Scale And Cash‑Flow Focus

Acquisition chatter has shifted the company’s immediate trajectory toward consolidation and a sharpened cash‑flow focus; balance‑sheet repair stands as the near‑term priority.

  • 2025-09-30

Celanese Corporation (NYSE:CE) Extends Liquidity While Near-Term Pressure Persists

Celanese heads into the coming weeks with improved liquidity but technicals and margins signal continued near-term pressure; fundamental cash generation supports downside containment. The balance of heavy leverage and modest free-cash yield frames a cautious bias.
Prev
1 … 61 62 63 64 65 66 67 … 79
Next

Introducing The World’s Most Dangerous Swing Trader

2025-09-04
Prev
1 … 47 48 49 50

Trending now

Comstock Resources, Inc. (NYSE:CRK) Leverages Haynesville Strength; Near-Term Momentum Favors Modest Upside
Bwin Interactive Entertainment AG (NASDAQ:BWIN) Projects Accelerating Recovery Amid Undervalued Fundamentals
Haemonetics Corporation (NYSE:HAE) Advances Cash-Driven Deleveraging While Margins Expand
Corcept Therapeutics Incorporated (NASDAQ:CORT) Endures Regulatory Rebuff; Volatility Likely To Persist